New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.1mg equivalent to desmopressin 0.0890 mg;   - tablet - 100 mcg - active: desmopressin acetate trihydrate 0.1mg equivalent to desmopressin 0.0890 mg   excipient: lactose monohydrate magnesium stearate maize starch povidone

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.2mg equivalent to desmopressin 0.178 mg;   - tablet - 200 mcg - active: desmopressin acetate trihydrate 0.2mg equivalent to desmopressin 0.178 mg   excipient: lactose monohydrate magnesium stearate maize starch povidone

Canada - English - Health Canada

aa pharma inc - desmopressin acetate - spray, metered dose - 10mcg - desmopressin acetate 10mcg - pituitary

Canada - English - Health Canada

meliapharm inc - desmopressin acetate trihydrate - tablet - 0.1mg - desmopressin acetate trihydrate 0.1mg - pituitary

Canada - English - Health Canada

meliapharm inc - desmopressin acetate trihydrate - tablet - 0.2mg - desmopressin acetate trihydrate 0.2mg - pituitary

United States - English - NLM (National Library of Medicine)

amring pharmaceuticals inc. - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.1 mg - central diabetes insipidus: desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. primary nocturnal enuresis: desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate tablets may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to an

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - desmopressin acetate - spray - 10microgram/1dose

Malta - English - Medicines Authority

ferring ireland limited united drug house, magna drive magna business park, citywest road dublin 24 , ireland - desmopressin acetate - nasal spray - desmopressin acetate 10 µg - pituitary and hypothalamic hormones and analogues

Malta - English - Medicines Authority

ferring pharmaceuticals limited - desmopressin acetate 0.1 mg/ml - nasal spray, solution

Ireland - English - HPRA (Health Products Regulatory Authority)

ferring ireland ltd - desmopressin acetate - nasal drops, solution - 100 microgram(s)/millilitre - vasopressin and analogues; desmopressin